“Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model” (2025) International Journal of Environmental Sciences, 11(12s), pp. 1360–1367. doi:10.64252/8crhea08.